Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

20211,790 citationsJournal Articlegreen Open Access

Authors

Einav G. Levin · Sheba Medical Center

Yaniv Lustig · Sheba Medical Center

Carmit Cohen · Sheba Medical Center

Ronen Fluss · Sheba Medical Center

Victoria Indenbaum · Sheba Medical Center

Sharon Amit · Sheba Medical Center

Ram Doolman · Sheba Medical Center

Keren Asraf ·

Abstract

Six months after receipt of the second dose of the BNT162b2 vaccine, humoral response was substantially decreased, especially among men, among persons 65 years of age or older, and among persons with immunosuppression.

Topics & Keywords

SARS-CoV-2 and COVID-19 Research Immunodeficiency and Autoimmune Disorders Immune responses and vaccinations

Publication Details

Published in: New England Journal of Medicine

Volume 385, Issue 24, pp. e84-e84

DOI: 10.1056/nejmoa2114583

Field-Weighted Citation Impact: 107.30

Command Palette

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Authors

Abstract

Topics & Keywords

Publication Details